Lateral epicondylitis treatment market featuring Cipla Inc. and Colfax Corp. among others |Technavio
NEW YORK, March 23, 2021 /PRNewswire/ -- The global lateral epicondylitis treatment market is expected to grow by USD 1.91 billion during 2021-2025, as per Technavio. This marks a significant market slow down compared to the 2020 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of almost 4%.
For the Right Perspective & Competitive Insights. Make confident decisions using our benchmarks and analysis.
Download Free Sample Report in Minutes
Read the 120-page report with TOC on "Lateral Epicondylitis Treatment Market Analysis Report by Type (Non-surgical treatment and Surgical treatment) and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts,2021-2025".
https://www.technavio.com/report/report/lateral-epicondylitis-treatment-market-industry-analysis
The lateral epicondylitis treatment market is driven by the rising awareness about lateral epicondylitis. In addition, the high incidence of sports injuries is anticipated to boost the growth of the lateral epicondylitis treatment market.
Lateral epicondylitis is common in people who participate in physical activities such as racket sports, hockey, canoeing, weightlifting, wrestling, rowing, and swimming. Moreover, it can also occur in people who apply more pressure on the extensor carpi radialis brevis and longus muscles of the forearm as a part of their work. These people observe severe and long-term pain around the elbow if the condition is left untreated. Hence, various government and non-government organizations are initiating certain programs to increase awareness among people and avoid delays in diagnosis. Hence, an increase in the number of organizations and institutes that raise awareness among people about lateral epicondylitis is expected to drive the growth of the global lateral epicondylitis treatment market during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Enquiry Before Buying
Major Five Lateral Epicondylitis Treatment Companies:
3M Co.
3M Co. operates business through Safety and Industrial, Transportation and Electronics, Health Care, Consumer, and Corporate and Unallocated. The company offers FUTURO Sport Tennis Elbow Support. It provides firm support to weak, sore, and injured tendons. Its tendon pad applies zoned pressure to help provide support to elbows affect by the symptoms of tendonitis.
Bayer AG
Bayer AG operates business through Pharmaceuticals, Crop science, and Consumer health. The company offers Aleve. It is an OTC NSAID that provides temporary relief from minor aches and pains caused by a variety of conditions. The active ingredient is 220 mg of naproxen sodium.
Cipla Inc.
Cipla Inc. operates business through Pharmaceuticals and New ventures. The company offers OMNI Gel. It is used to relieve pain associated with recent muscle or joint injuries such as sprains, strains, or sports injuries.
Colfax Corp.
Colfax Corp. operates business through Fabrication technology and Medical technology. The company offers ProCare Tennis Elbow Support. It combines a neoprene band with a bladder filled with microspheres for compression over the tendon insertion point. It is ideal for medial epicondylitis and lateral epicondylitis.
GlaxoSmithKline Plc
GlaxoSmithKline Plc operates business through Pharmaceuticals, Consumer Healthcare, and Vaccines. The company offers Voltaren. Voltaren (diclofenac sodium enteric-coated tablets) is a benzene-acetic acid derivative. It is available as delayed-release (enteric-coated) tablets of 75 mg for oral administration.
Lateral Epicondylitis Treatment Market Type Outlook (Revenue, USD billion, 2020-2025)
- Non-surgical treatment - size and forecast 2020-2025
- Surgical treatment - size and forecast 2020-2025
Lateral Epicondylitis Treatment Market Geography Outlook (Revenue, USD billion, 2020-2025)
- North America - size and forecast 2020-2025
- Europe - size and forecast 2020-2025
- Asia - size and forecast 2020-2025
- ROW - size and forecast 2020-2025
Are you a start-up willing to make it big in the business?
Grab an exclusive Report
Related Reports on Health Care Include:
Global Blepharitis Drugs Market- The blepharitis drugs market is segmented by product (steroids and antibiotics), geography (North America, Europe, Asia, and ROW), and key vendors.
Get an Exclusive Free Sample Report
Global Active Pharmaceutical Ingredients Market- The active pharmaceutical ingredients market is segmented by manufacturing type (captive APIs and contract APIs) and geography (APAC, North America, Europe, and ROW).
Get an Exclusive Free Sample Report
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Report Page: https://www.technavio.com/report/lateral-epicondylitis-treatment-market-industry-analysis
SOURCE Technavio
Share this article